Report Scope & Overview:
Urolithiasis Management Device Market which was valued at USD 1.48 billion in 2021, would rocket up to USD 2.34 billion by 2029, and is expected to undergo a CAGR of 5.90% during the 2022 to 2029.
Global Urolithiasis Management Device Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Urolithiasis Management Device Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Urolithiasis Management Device market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Urolithiasis Management Device market research is expected to experience further growth and innovation in the coming years.
Urolithiasis Management Device Market Key Trends
Minimally invasive procedures: The market was witnessing a shift towards minimally invasive procedures for the management of urolithiasis. Techniques such as extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and percutaneous nephrolithotomy (PCNL) were gaining popularity due to their reduced invasiveness and shorter recovery times compared to traditional surgical approaches.
Technological advancements in lithotripsy: Lithotripsy, the non-invasive procedure for breaking down kidney stones, was experiencing advancements in technology. Shock wave lithotripsy (SWL) devices were becoming more efficient, with improved targeting capabilities and enhanced stone fragmentation rates. Additionally, newer energy sources and techniques, such as laser lithotripsy, were being developed to offer more precise and effective stone fragmentation.
Advanced imaging techniques: Diagnostic imaging played a crucial role in the management of urolithiasis. The market was witnessing advancements in imaging techniques such as computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI). These technologies provided detailed visualization of kidney stones, allowing healthcare professionals to accurately assess stone size, location, and composition, and plan appropriate treatment strategies.
Integration of robotics and endoscopy: Robotic-assisted surgery and advanced endoscopic techniques were being increasingly integrated into urolithiasis management. Robotic systems offered enhanced precision, dexterity, and visualization, allowing surgeons to perform complex procedures with improved outcomes. Endoscopic devices, including flexible ureteroscopes and laser fiber delivery systems, were becoming more sophisticated, enabling efficient stone removal and reducing the need for open surgeries.
Disposable and single-use devices: The market was witnessing a rise in the adoption of disposable and single-use urolithiasis management devices. These devices offered several advantages, including reduced risk of cross-contamination, improved safety, and convenience. Single-use devices eliminated the need for reprocessing and sterilization, streamlining workflows in healthcare settings.
Holistic approach to stone prevention: There was an increasing focus on a holistic approach to urolithiasis management, including stone prevention strategies. The market saw the development of devices and solutions aimed at evaluating and addressing underlying metabolic and dietary factors that contribute to stone formation. These included devices for urinary metabolic analysis, patient education tools, and mobile applications for tracking hydration and dietary habits.
Patient-centered care and enhanced patient experience: The market trends were also leaning towards patient-centered care and enhanced patient experience. Urolithiasis management device manufacturers were focusing on designing devices that were more comfortable, less invasive, and offered improved patient outcomes. Patient-friendly features such as ergonomic designs, reduced procedure time, and better pain management were being incorporated into device development
Market Segmentations:
Global Urolithiasis Management Device Market: By Company
• Allengers Medical Systems
• Boston Scientific
• C.R. Bard
• Cook Medical
• ConMed
• DirexGroup
• Dornier MedTech
• Guangzhou Potent Optotronic Technology
• HealthTronics
• Karl Storz
• Lumenis
• Olympus
• Richard Wolf
• Siemens Healthcare
Global Urolithiasis Management Device Market: By Type
• Extracorporeal Shock Wave Lithotripsy (Eswl)
• Intracorporeal Lithotripsy
• Percutaneous Nephrolithotomy
• Others
Global Urolithiasis Management Device Market: By Application
• Hospitals
• Clinics
• Others
Global Urolithiasis Management Device Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Urolithiasis Management Device market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2021 | USD 1.48 billion |
| Market Size 2029 | USD 2.34 billion |
| Compound Annual Growth Rate (CAGR) | Cagr of 5.90%(2022-2029) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Extracorporeal Shock Wave Lithotripsy (Eswl) • Intracorporeal Lithotripsy • Percutaneous Nephrolithotomy • Others |
| By Application | • Hospitals • Clinics • Others |
| Key Companies Profiled | • Allengers Medical Systems • Boston Scientific • C.R. Bard • Cook Medical • ConMed • DirexGroup • Dornier MedTech • Guangzhou Potent Optotronic Technology • HealthTronics • Karl Storz • Lumenis • Olympus • Richard Wolf • Siemens Healthcare |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Urolithiasis Management Device Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Urolithiasis Management Device Market Study:
The objectives of Urolithiasis Management Device market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Urolithiasis Management Device market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
Urolithiasis Management Device Market which was valued at USD 1.48 billion in 2021, would rocket up to USD 2.34 billion by 2029, and is expected to undergo a CAGR of 5.90% during the forecast period 2022 to 2029.
The major factors driving the growth of the urolithiasis management device market include the increasing prevalence of urolithiasis (kidney stones), the growing geriatric population, dietary and lifestyle changes leading to stone formation, advancements in minimally invasive procedures for stone removal, and the rising demand for effective and efficient stone management devices.
The market offers various types of urolithiasis management devices, including lithotripters (shock wave lithotripsy devices), ureteroscopes, laser systems, retrieval devices (stone baskets, forceps), stents, and percutaneous nephrolithotomy devices. These devices are used for the diagnosis, treatment, and removal of kidney stones.
North America currently holds the largest market share in the urolithiasis management device market, followed by Europe. However, the market is also witnessing significant growth in the Asia Pacific region.
The key players in the urolithiasis management device market include Olympus Corporation, Boston Scientific Corporation, Cook Medical LLC, Coloplast Group, C. R. Bard, Inc. (BD), and Richard Wolf GmbH, among others.
TABLE OF CONTENT
1.1 Product Overview and Scope of Urolithiasis Management Device
1.2 Urolithiasis Management Device Segment by Type
1.2.1 Global Urolithiasis Management Device Market Value Comparison by Type (2023-2029)
1.2.2 Extracorporeal Shock Wave Lithotripsy (Eswl)
1.2.3 Intracorporeal Lithotripsy
1.2.4 Percutaneous Nephrolithotomy
1.2.5 Others
1.3 Urolithiasis Management Device Segment by Application
1.3.1 Global Urolithiasis Management Device Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Urolithiasis Management Device Market Size Estimates and Forecasts
1.4.1 Global Urolithiasis Management Device Revenue 2017-2032
1.4.2 Global Urolithiasis Management Device Sales 2017-2032
1.4.3 Global Urolithiasis Management Device Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Urolithiasis Management Device Market Competition by Manufacturers
2.1 Global Urolithiasis Management Device Sales Market Share by Manufacturers (2017-2023)
2.2 Global Urolithiasis Management Device Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Urolithiasis Management Device Average Price by Manufacturers (2017-2023)
2.4 Global Urolithiasis Management Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Urolithiasis Management Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urolithiasis Management Device, Product Type & Application
2.7 Urolithiasis Management Device Market Competitive Situation and Trends
2.7.1 Urolithiasis Management Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Urolithiasis Management Device Players Market Share by Revenue
2.7.3 Global Urolithiasis Management Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urolithiasis Management Device Retrospective Market Scenario by Region
3.1 Global Urolithiasis Management Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Urolithiasis Management Device Global Urolithiasis Management Device Sales by Region: 2017-2032
3.2.1 Global Urolithiasis Management Device Sales by Region: 2017-2023
3.2.2 Global Urolithiasis Management Device Sales by Region: 2023-2032
3.3 Global Urolithiasis Management Device Global Urolithiasis Management Device Revenue by Region: 2017-2032
3.3.1 Global Urolithiasis Management Device Revenue by Region: 2017-2023
3.3.2 Global Urolithiasis Management Device Revenue by Region: 2023-2032
3.4 North America Urolithiasis Management Device Market Facts & Figures by Country
3.4.1 North America Urolithiasis Management Device Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Urolithiasis Management Device Sales by Country (2017-2032)
3.4.3 North America Urolithiasis Management Device Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Urolithiasis Management Device Market Facts & Figures by Country
3.5.1 Europe Urolithiasis Management Device Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Urolithiasis Management Device Sales by Country (2017-2032)
3.5.3 Europe Urolithiasis Management Device Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urolithiasis Management Device Market Facts & Figures by Country
3.6.1 Asia Pacific Urolithiasis Management Device Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Urolithiasis Management Device Sales by Country (2017-2032)
3.6.3 Asia Pacific Urolithiasis Management Device Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Urolithiasis Management Device Market Facts & Figures by Country
3.7.1 Latin America Urolithiasis Management Device Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Urolithiasis Management Device Sales by Country (2017-2032)
3.7.3 Latin America Urolithiasis Management Device Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Urolithiasis Management Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Urolithiasis Management Device Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Urolithiasis Management Device Sales by Country (2017-2032)
3.8.3 Middle East and Africa Urolithiasis Management Device Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Urolithiasis Management Device Sales by Type (2017-2032)
4.1.1 Global Urolithiasis Management Device Sales by Type (2017-2023)
4.1.2 Global Urolithiasis Management Device Sales by Type (2023-2032)
4.1.3 Global Urolithiasis Management Device Sales Market Share by Type (2017-2032)
4.2 Global Urolithiasis Management Device Revenue by Type (2017-2032)
4.2.1 Global Urolithiasis Management Device Revenue by Type (2017-2023)
4.2.2 Global Urolithiasis Management Device Revenue by Type (2023-2032)
4.2.3 Global Urolithiasis Management Device Revenue Market Share by Type (2017-2032)
4.3 Global Urolithiasis Management Device Price by Type (2017-2032)
5 Segment by Application
5.1 Global Urolithiasis Management Device Sales by Application (2017-2032)
5.1.1 Global Urolithiasis Management Device Sales by Application (2017-2023)
5.1.2 Global Urolithiasis Management Device Sales by Application (2023-2032)
5.1.3 Global Urolithiasis Management Device Sales Market Share by Application (2017-2032)
5.2 Global Urolithiasis Management Device Revenue by Application (2017-2032)
5.2.1 Global Urolithiasis Management Device Revenue by Application (2017-2023)
5.2.2 Global Urolithiasis Management Device Revenue by Application (2023-2032)
5.2.3 Global Urolithiasis Management Device Revenue Market Share by Application (2017-2032)
5.3 Global Urolithiasis Management Device Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Allengers Medical Systems
6.1.1 Allengers Medical Systems Corporation Information
6.1.2 Allengers Medical Systems Description and Business Overview
6.1.3 Allengers Medical Systems Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Allengers Medical Systems Urolithiasis Management Device Product Portfolio
6.1.5 Allengers Medical Systems Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Boston Scientific Urolithiasis Management Device Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 C.R. Bard
6.3.1 C.R. Bard Corporation Information
6.3.2 C.R. Bard Description and Business Overview
6.3.3 C.R. Bard Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.3.4 C.R. Bard Urolithiasis Management Device Product Portfolio
6.3.5 C.R. Bard Recent Developments/Updates
6.4 Cook Medical
6.4.1 Cook Medical Corporation Information
6.4.2 Cook Medical Description and Business Overview
6.4.3 Cook Medical Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Cook Medical Urolithiasis Management Device Product Portfolio
6.4.5 Cook Medical Recent Developments/Updates
6.5 ConMed
6.5.1 ConMed Corporation Information
6.5.2 ConMed Description and Business Overview
6.5.3 ConMed Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.5.4 ConMed Urolithiasis Management Device Product Portfolio
6.5.5 ConMed Recent Developments/Updates
6.6 DirexGroup
6.6.1 DirexGroup Corporation Information
6.6.2 DirexGroup Description and Business Overview
6.6.3 DirexGroup Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.6.4 DirexGroup Urolithiasis Management Device Product Portfolio
6.6.5 DirexGroup Recent Developments/Updates
6.7 Dornier MedTech
6.6.1 Dornier MedTech Corporation Information
6.6.2 Dornier MedTech Description and Business Overview
6.6.3 Dornier MedTech Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Dornier MedTech Urolithiasis Management Device Product Portfolio
6.7.5 Dornier MedTech Recent Developments/Updates
6.8 Guangzhou Potent Optotronic Technology
6.8.1 Guangzhou Potent Optotronic Technology Corporation Information
6.8.2 Guangzhou Potent Optotronic Technology Description and Business Overview
6.8.3 Guangzhou Potent Optotronic Technology Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Guangzhou Potent Optotronic Technology Urolithiasis Management Device Product Portfolio
6.8.5 Guangzhou Potent Optotronic Technology Recent Developments/Updates
6.9 HealthTronics
6.9.1 HealthTronics Corporation Information
6.9.2 HealthTronics Description and Business Overview
6.9.3 HealthTronics Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.9.4 HealthTronics Urolithiasis Management Device Product Portfolio
6.9.5 HealthTronics Recent Developments/Updates
6.10 Karl Storz
6.10.1 Karl Storz Corporation Information
6.10.2 Karl Storz Description and Business Overview
6.10.3 Karl Storz Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Karl Storz Urolithiasis Management Device Product Portfolio
6.10.5 Karl Storz Recent Developments/Updates
6.11 Lumenis
6.11.1 Lumenis Corporation Information
6.11.2 Lumenis Urolithiasis Management Device Description and Business Overview
6.11.3 Lumenis Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Lumenis Urolithiasis Management Device Product Portfolio
6.11.5 Lumenis Recent Developments/Updates
6.12 Olympus
6.12.1 Olympus Corporation Information
6.12.2 Olympus Urolithiasis Management Device Description and Business Overview
6.12.3 Olympus Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Olympus Urolithiasis Management Device Product Portfolio
6.12.5 Olympus Recent Developments/Updates
6.13 Richard Wolf
6.13.1 Richard Wolf Corporation Information
6.13.2 Richard Wolf Urolithiasis Management Device Description and Business Overview
6.13.3 Richard Wolf Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Richard Wolf Urolithiasis Management Device Product Portfolio
6.13.5 Richard Wolf Recent Developments/Updates
6.14 Siemens Healthcare
6.14.1 Siemens Healthcare Corporation Information
6.14.2 Siemens Healthcare Urolithiasis Management Device Description and Business Overview
6.14.3 Siemens Healthcare Urolithiasis Management Device Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Siemens Healthcare Urolithiasis Management Device Product Portfolio
6.14.5 Siemens Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urolithiasis Management Device Industry Chain Analysis
7.2 Urolithiasis Management Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urolithiasis Management Device Production Mode & Process
7.4 Urolithiasis Management Device Sales and Marketing
7.4.1 Urolithiasis Management Device Sales Channels
7.4.2 Urolithiasis Management Device Distributors
7.5 Urolithiasis Management Device Customers
8 Urolithiasis Management Device Market Dynamics
8.1 Urolithiasis Management Device Industry Trends
8.2 Urolithiasis Management Device Market Drivers
8.3 Urolithiasis Management Device Market Challenges
8.4 Urolithiasis Management Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Allengers Medical Systems
Boston Scientific
C.R. Bard
Cook Medical
ConMed
DirexGroup
Dornier MedTech
Guangzhou Potent Optotronic Technology
HealthTronics
Karl Storz
Lumenis
Olympus
Richard Wolf
Siemens Healthcare
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast